🚨 Alpha Signal: Hanwha Life Insurance Co., Ltd. (088350.KS) 📈 Price Surge 6.2%
🚨 Alpha Bond Signal Alert
Bond Market Analysis
Hanwha Life Insurance Co., Ltd. (088350.KS) +6.2% at 2026-05-18 10:31 JST from 2026-05-18 09:30 JST
| 🕒 Time (Local) | 🌐 English Summary | 📰 Original Headline (linked) |
|---|---|---|
| 2026-05-18 00:30 KST | Donga reports Hanwha Life Financial Services held its 2026 annual awards ceremony for top planners and managers; Chairman Kim Seung‑yeon praises the group’s AI‑driven financial transformation and calls planners “the true heroes and pride of Hanwha Life,” reinforcing salesforce morale and brand image. (donga.com) | 한화생명 ‘2026 연도대상’ 시상식 |
| 2026-05-17 17:49 KST | Korea Financial News highlights that CEOs Kwon Hyuk‑woong and Lee Kyung‑keun boosted Hanwha Life’s new contract CSM multiple to 9.8x from 7.8x YoY by shifting toward longer‑tenor whole‑life policies; new business CSM rose 25.1% to ₩6.11 tn, underscoring structurally higher profitability and capital efficiency. (fntimes.com) | [권혁웅·이경근 한화생명 대표, 중장기납 종신보험 확대 신계약CSM배수 2배 제고 \[2026 금융사 1분기 실적\]](https://www.fntimes.com/html/view.php?ud=202605122118117418a55064dd1_18) |
| 2026-05-15 08:11 KST | Hans Economy reports Hanwha Life’s Q1 2026 consolidated net income reached ₩381.6 bn, up 29% YoY, driven by improved investment income and growth of domestic and overseas subsidiaries, and frames the company’s shift toward a diversified “comprehensive financial group” model with non‑insurance and overseas investments as new growth pillars. (msale.mimint.co.kr) | 한화생명, ‘종합금융그룹’ 전환 가속…신 성장축 ‘비보험·해외투자’ |
| 2026-05-14 15:55 KST | Official DART filing of the Q1 2026 quarterly report confirms consolidated revenue of about ₩3.16 tn, operating profit of ₩480.8 bn and net profit of ₩381.6 bn, marking the highest operating profit in the last five quarters and validating the earlier “earnings surprise” narrative. (dart.fss.or.kr) | 분기보고서 (2026.03) |
| 2026-05-14 (date only, KST) | Samsung Securities’ company update maintains a **BUY** rating and raises Hanwha Life’s target price to ₩5,500 (from ₩4,400), citing stronger sustainable ROE, improved capital ratios and higher target P/B, implying double‑digit upside from the then share price. (samsungpop.com) | 한화생명 (088350) COMPANY UPDATE – 삼성증권 리포트 |
| 2026-05-14 09:29 KST | News2day relays Hana Securities’ report keeping a **Buy** on Hanwha Life with a higher TP of ₩7,300, noting Q1 2026 separate net profit of ₩247.8 bn beat consensus by 47% and sharply upgrading 2026–27 earnings forecasts on robust investment gains and growing overseas profit contribution. (news2day.co.kr) | “한화생명 1분기 순익 2478억…컨센서스 47% 상회”\<하나證> |
| 2026-05-14 07:54 KST | The Zirashi summarizes Hanwha Life’s finalized Q1 2026 results: operating profit ₩480.8 bn and net profit ₩381.6 bn, the highest in a year, driven by growth in protection‑type CSM and solid investment returns; it characterizes the quarter as a “earnings rebound” and notes strengthened downside support and further upside potential as Korea’s value‑up program unfolds. (thezirashi.com) | 한화생명 1분기 순이익 3,800억 돌파! 보험 본업 경쟁력으로 이뤄낸 ‘깜짝 실적’ 📈 |
| 2026-05-13 10:37 KST | BigDataNews reports Q1 2026 consolidated net income of ₩381.6 bn (+29% YoY) and separate net income of ₩247.8 bn (+103% YoY), highlighting a 437.8% surge in investment profit, expansion of protection APE and a rise in both new business and in‑force CSM; K‑ICS ratio is estimated at 162%, reinforcing the view of improving earnings quality and capital strength. (thebigdata.co.kr) | 한화생명, 1분기 순익 3816억·29%↑…투자손익 437% 폭증 |
| 2026-05-13 07:57 KST | BeyondPost reports that Hanwha Life ranked **No.1** in the May 2026 life‑insurance brand reputation index compiled by Korea Corporate Reputation Research Institute, based on 22.86 million big‑data points across consumption, media, communication, community and ESG metrics, supporting positive brand perception despite a lower absolute index vs. the prior month. (beyondpost.co.kr) | 한화생명, 생명보험 브랜드평판 2026년 5월…1위 |
| 2026-05-13 (date only, KST) | A new research report on the Hankyung Consensus platform keeps a **Buy** rating and raises Hanwha Life’s target price to ₩6,100 (from ₩5,800) as of May 13, citing the Q1 2026 earnings beat, higher CSM and improved K‑ICS ratio, implying substantial upside from the then‑current share price. (consensus.hankyung.com) | 한화생명 (088350) 리포트 – 목표주가 6,100원 (Buy 유지) |
| 2026-05-12 16:21 KST | ChosunBiz (English edition) reports that Q1 2026 consolidated net income rose 29% YoY to ₩381.6 bn on a 54.7% jump in revenue and a 29.5% increase in operating profit, driven by expansion in protection‑type APE and a 25.1% rise in new business CSM, with CSM profitability improving from 7.8x to 9.8x and K‑ICS ratio expected at 162%. (biz.chosun.com) | Hanwha Life boosts Q1 profit 29% on protection sales and stronger CSM |
| 2026-05-12 14:15 KST | Yonhap (Korean) reports via regulatory filing that Q1 2026 consolidated net income was ₩381.6 bn (+29% YoY), operating profit ₩480.8 bn (+29.5% YoY) and sales ₩9.9852 tn (+54.7% YoY), noting improved profitability from protection‑focused new business and better investment results, along with an expected K‑ICS ratio of 162%. (yna.co.kr) | 한화생명 1분기 순익 3천816억원, 29%↑…매출도 55% 늘어(종합) |
| 2026-05-12 13:39 KST | DART “영업(잠정)실적(공정공시)” filing (summarized by Awakeplus and DigitalToday) discloses Q1 2026 separate‑basis sales of ₩5.3127 tn (+57.8% YoY), operating profit ₩279.9 bn (+123.8% YoY) and net profit ₩247.8 bn (+103.2% YoY), confirming a sharp earnings rebound from a small loss in Q4 2025 and setting up the subsequent positive broker revisions and sentiment. (awakeplus.co.kr) | 영업(잠정)실적(공정공시) |
Don't miss what's next. Subscribe to Morning Espresso: